Peptide Library / Detail
Cardiogen
Half-life
Unknown - insufficient pharmacokinetic data
Delivery
Subcutaneous or intramuscular injection
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Purchase
Description
Cardiogen is a synthetic short peptide bioregulator designed to support cardiac tissue function and cellular health. Originally developed as part of peptide bioregulation research, it has been studied for its effects on myocardial tissue development and age-related cellular changes. Research suggests tissue-specific regulatory effects on cardiomyocytes and fibroblast differentiation.
Usage
Typical research protocols involve subcutaneous or intramuscular administration at doses ranging from 10-20 mg per course, administered 1-2 times daily for 10-20 day cycles. Courses are often repeated every 3-6 months in experimental settings. Dosing and duration vary significantly across studies.
Mechanism of Action
Cardiogen acts as a peptide bioregulator that influences gene expression and cellular differentiation in cardiac tissue. It modulates signal factors involved in fibroblast differentiation and appears to support cellular function in both young and aged tissues. The peptide demonstrates tissue-specific effects on myocardial cell cultures, promoting development and potentially counteracting age-related cellular decline.
Benefits(7)
- Supports cardiac tissue function and myocardial cell development
- May promote cellular regeneration in aging cardiac tissue
- Demonstrates tissue-specific regulatory effects on cardiomyocytes
- Modulates fibroblast differentiation signal factors
- Shows potential tumor-modifying effects in experimental models (M-1 sarcoma studies)
- Supports age-related cellular health maintenance
- May enhance organotypic tissue culture development
Side Effects(6)
- Limited human safety data available
- Potential injection site reactions
- Unknown long-term effects in humans
- Possible allergic reactions or hypersensitivity
- Insufficient data on drug interactions
- Not well-characterized in clinical populations